Open Access
Med Buccale Chir Buccale
Volume 23, Number 1, Janvier 2017
Page(s) 51 - 59
Section Cas clinique et revue de la littérature / Up-to date review and case report
Published online 01 February 2017
  1. Mulliken JB, Glowacki J. Hemangiomas and vascular malformations in infants and children: A classification based on endothelial characteristics. Plast Reconstr Surg 1982;69(3):412-422. [CrossRef] [PubMed] [Google Scholar]
  2. Wassef M, Blei F, Adams D, Alomari A, Baselga E, Borenstein A. Vascular anomalies classifcation : recommendations from the international society for the study of vascular anomalies. Pediatrics 2015;136(1):e203-214. [CrossRef] [PubMed] [Google Scholar]
  3. Ernemann U, Kramer U, Miller S, Bisdas S, Rebmann H, Breuninger H, et al. Current concepts in the classification, diagnosis and treatment of vascular anomalies. Eur J Radiol 2010;75(1):2-11. [CrossRef] [PubMed] [Google Scholar]
  4. Mulligan PR, Prajapati HJS, Martin LG, Patel TH. Vascular anomalies: classification, imaging characteristics and implications for interventional radiology treatment approaches. Br J Radiol 2014;87(1035):20130392. [CrossRef] [PubMed] [Google Scholar]
  5. Ethunandan M, Mellor TK. Haemangiomas and vascular malformations of the maxillofacial region--a review. Br J Oral Maxillofac Surg 2006;44(4):263-272. [CrossRef] [PubMed] [Google Scholar]
  6. Bonet-Coloma C, Minguez-Martinez I, Aloy-Prosper A, Rubio-Serrana M, Penarrocha-Diago MA, Penarrocha-Diago M. Clinical characteristics, treatment and evolution in 14 cases of pediatric orofacial lymphangioma. J Oral Maxillofac Surg 2011;69:e96-99. [CrossRef] [PubMed] [Google Scholar]
  7. Brennan TD, Miller AS, Chen SY. Lymphangiomas of the oral cavity: a clinicopathologic, immunohistochemical, and electron-microscopic study. J Oral Maxillofac Surg 1997;55(9):932-935. [CrossRef] [PubMed] [Google Scholar]
  8. Nosher JL. Vascular anomalies: A pictorial review of nomenclature, diagnosis and treatment. World J Radiol 2014;6(9):677. [CrossRef] [PubMed] [Google Scholar]
  9. Zachariades N, Koundouris I. Lymphangioma of the oral cavity: report of a case. J Oral Med 1984;39(1):33-34. [PubMed] [Google Scholar]
  10. Wiegand S, Eivazi B, Barth PJ, von Rautenfeld DB, Folz BJ, Mandic R, et al. Pathogenesis of lymphangiomas. Virchows Arch 2008; 453(1):1-8. [CrossRef] [PubMed] [Google Scholar]
  11. Kukk E, Lymboussaki A, Taira S, Kaipainen A, Jeltsch M, Joukov V, et al. VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular. Development 1996; 122(12):3829-3837. [PubMed] [Google Scholar]
  12. Adams MT, Saltzman B, Perkins JA. Head and neck lymphatic malformation treatment: a systematic review. Otolaryngol Head Neck Surg 2012;147(4):627-639. [CrossRef] [PubMed] [Google Scholar]
  13. Riché MC. [Lymphangioma]. Rev Prat 1992;42(16):2041-2043. [PubMed] [Google Scholar]
  14. Enjolras O, Herbreteau D, Lemarchand F, Riche MC, Laurian C, Brette MD, et al. [Hemangiomas and superficial vascular malformations: classification]. J Mal Vasc 1992;17(1):2-19. [PubMed] [Google Scholar]
  15. Segado Arenas A, Flores González J-C, Rubio Quiñones F, Quintero Otero S, Hernández González A, Pantoja Rosso S. Obstruction iatrogène sévère de la voie aérienne par un lymphangiome lingual. Arch Pédiatrie 2011;18(9):983-986. [CrossRef] [Google Scholar]
  16. Zhou Q, Zheng JW, Mai HM, Luo QF, Fan XD, Su LX, et al. Treatment guidelines of lymphatic malformations of the head and neck. Oral Oncol 2011;47(12):1105-1109. [CrossRef] [PubMed] [Google Scholar]
  17. Turner C, Gross S. Treatment of recurrent suprahyoid cervicofacial lymphangioma with intravenous cyclophosphamide. Am J Pediatr Hematol Oncol 1994;16(4):325-328. [PubMed] [Google Scholar]
  18. Thottam PJ, Al-Barazi R, Madgy DN, Rozzelle A. Submucosal resection of a microcystic oropharyngeal lymphatic malformation using radiofrequency ablation. Int J Pediatr Otorhinolaryngol 2013; 77(9):1589-1592. [PubMed] [Google Scholar]
  19. Pierrot S, Manach Y, Couloigner V. Lymphangiomes cervicofaciaux : imagerie, diagnostic et traitement. EMC - Oto-Rhino-Laryngol 2011;6(2):1-7. [CrossRef] [Google Scholar]
  20. Moser T, Chapot R, Jahn C, Salvador D, Baldi S, Beaujeux R. Imagerie des anomalies vasculaires des tissus mous : diagnostic et traitement. Feuill Radiol 2008;45(1):13-36. [CrossRef] [Google Scholar]
  21. Katsoulas N, Tosios KI, Argyris P, Koutlas IG, Sklavounou A. Lymphangioma circumscriptum, angiokeratoma, or superficial vascular ectasia with epithelial hyperplasia? Oral Surg Oral Med Oral Pathol Oral Radiol 2014;118(2):e53-57. [PubMed] [Google Scholar]
  22. Lavie A, Desouches C, Casanova D, Bardot J, Magalon G. Traitement chirurgical des malformations lymphatiques. Ann Chir Plast Esthét 2006;51(4-5):433-439. [CrossRef] [Google Scholar]
  23. Chakravarti A, Bhargava R. Lymphangioma circumscriptum of the tongue in children: successful treatment using intralesional bleomycin. Int J Pediatr Otorhinolaryngol 2013;77(8):1367-1369. [PubMed] [Google Scholar]
  24. Acevedo JL, Shah RK, Brietzke SE. Nonsurgical therapies for lymphangiomas: a systematic review. Otolaryngol Head Neck Surg 2008;138(4):418-424. [PubMed] [Google Scholar]
  25. Colbert SD, Seager L, Haider F, Evans BT, Anand R, Brennan PA. Lymphatic malformations of the head and neck-current concepts in management. Br J Oral Maxillofac Surg 2013;51(2):98-102. [CrossRef] [PubMed] [Google Scholar]
  26. Mathur NN, Rana I, Bothra R, Dhawan R, Kathuria G, Pradhan T. Bleomycin sclerotherapy in congenital lymphatic and vascular malformations of head and neck. Int J Pediatr Otorhinolaryngol 2005;69(1):75-80. [EDP Sciences] [PubMed] [Google Scholar]
  27. Won JH, Kim BM, Kim C-H, Park SW, Kim MD. Percutaneous sclerotherapy of lymphangiomas with acetic acid. J Vasc Interv Radiol 2004;15(6):595-600. [CrossRef] [PubMed] [Google Scholar]
  28. Churchill P, Otal D, Pemberton J, Ali A, Flageole H, Walton JM. Sclerotherapy for lymphatic malformations in children: a scoping review. J Pediatr Surg 2011;46(5):912-922. [CrossRef] [PubMed] [Google Scholar]
  29. Cable BB, Mair EA. Radiofrequency ablation of lymphangiomatous macroglossia. Laryngoscope 2001;111(10):1859-1861. [CrossRef] [PubMed] [Google Scholar]
  30. Leboulanger N, Roger G, Caze A, Enjolras O, Denoyelle F, Garabedian EN. Utility of radiofrequency ablation for haemorrhagic lingual lymphangioma. Int J Pediatr Otorhinolaryngol 2008; 72(7):953-958. [PubMed] [Google Scholar]
  31. Reinhardt MA, Nelson SC, Sencer SF, Bostrom BC, Kurachek SC, Nesbit ME. Treatment of childhood lymphangiomas with interferon-alpha. J Pediatr Hematol Oncol 1997;19(3):232-236. [CrossRef] [PubMed] [Google Scholar]
  32. Timke C, Krause MF, Oppermann H-C, Leuschner I, Claviez A. Interferon alpha 2b treatment in an eleven-year-old boy with disseminated lymphangiomatosis. Pediatr Blood Cancer 2007;48(1):108-111. [PubMed] [Google Scholar]
  33. Savas JA, Ledon J, Franca K, Chacon A, Zaiac M, Nouri K. Carbon dioxide laser for the treatment of microcystic lymphatic malformations (lymphangioma circumscriptum): a systematic review. Dermatol Surg 2013;39(8):1147-1157. [PubMed] [Google Scholar]
  34. Sasaki R, Negishi K, Akita H, Suzuki K, Matsunaga K. Successful treatment of congenital lymphangioma circumscriptum of the vulva with CO2 and long-pulsed Nd:YAG Lasers. Case Rep Dermatol 2014;6(1):1-4. [CrossRef] [PubMed] [Google Scholar]
  35. Ozeki M, Fukao T, Kondo N. Propranolol for intractable diffuse lymphangiomatosis. N Engl J Med 2011;364(14):1380-1382. [CrossRef] [PubMed] [Google Scholar]
  36. Leboulanger N. Propranolol therapy for hemorrhagic lymphangioma of the tongue. Arch Otolaryngol Neck Surg 2011;137(8):813. [CrossRef] [Google Scholar]
  37. Maruani A, Brown S, Lorette G, Pondaven-Letourmy S, Herbreteau D, Eisenbaum A. Lack of effect of propranolol in the treatment of lymphangioma in two children. Pediatr Dermatol 2013;30(3):383-385. [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.